Find in Library
Search millions of books, articles, and more
Indexed Open Access Databases
The Alteration of Intestinal Microbiota Profile and Immune Response in <i>Epinephelus coioides</i> during Pathogen Infection
oleh: Joan Tang Xiao Joe, Yung-Che Tseng, Jen-Leih Wu, Ming-Wei Lu
Format: | Article |
---|---|
Diterbitkan: | MDPI AG 2021-01-01 |
Deskripsi
<i>Epinephelus coioides</i>, or grouper, is a high economic value fish species that plays an important role in the aquaculture industry in Asia. However, both viral and bacterial diseases have threatened grouper for many years, especially nervous necrosis virus, grouper iridovirus and <i>Vibrio harveyi</i>, which have caused a bottleneck in the grouper industry. Currently, intestinal microbiota can provide novel insights into the pathogenesis-related factors involved in pathogen infection. Hence, we investigated the comparison of intestinal microbiota communities in control group and pathogen-infected grouper through high-throughput sequencing of the 16S rRNA gene. Our results showed that microbial diversity was decreased, whereas microbial richness was increased during pathogen infection. The individuals in each group were distributed distinctly on the PLSDA diagram, especially the GIV group. <i>Proteobacteria</i> and <i>Firmicutes</i> were the most abundant bacterial phyla in all groups. Interestingly, beneficial genera, <i>Faecalibacterium</i> and <i>Bifidobacterium</i>, predominated in the intestines of the control group. In contrast, the intestines of pathogen-infected grouper had higher levels of harmful genera such as <i>Sphingomonas</i>, <i>Atopostipes</i>, <i>Staphylococcus</i> and <i>Acinetobacter.</i> Additionally, we investigated the expression levels of innate and adaptive immune-related genes after viral and bacterial infection. The results revealed that immunoglobulin T and proinflammatory cytokine levels in the intestine increased after pathogen infection. Through these unique bacterial compositions in diseased and uninfected fish, we could establish a novel therapeutic approach and bacterial marker for preventing and controlling these diseases.